methyldopa has been researched along with fibrinogen in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tovi, D | 1 |
| Day, TW; Mendoza, F | 1 |
| Fairley, KF; Kincaid-Smith, PS; Whitworth, JA | 1 |
1 review(s) available for methyldopa and fibrinogen
| Article | Year |
|---|---|
Pharmacologic management of Raynaud's phenomenon.
Topics: Blood Platelets; Blood Viscosity; Fibrinogen; Griseofulvin; Humans; Methyldopa; Nifedipine; Parasympatholytics; Phenoxybenzamine; Raynaud Disease; Receptors, Adrenergic; Reserpine | 1984 |
2 other study(ies) available for methyldopa and fibrinogen
| Article | Year |
|---|---|
The use of antifibrinolytic drugs to prevent early recurrent aneurysmal subarachnoid haemorrhage.
Topics: Adult; Aged; Antifibrinolytic Agents; Blood Cell Count; Cerebral Angiography; Cyclohexanecarboxylic Acids; Factor IX; Factor V; Factor VII; Factor X; Female; Fibrin; Fibrinogen; Fibrinolytic Agents; Humans; Hydralazine; Intracranial Aneurysm; Male; Methyldopa; Middle Aged; Phenytoin; Prothrombin; Recurrence; Subarachnoid Hemorrhage | 1973 |
Mesangial IgA nephropathy in pregnancy.
Topics: Acute Kidney Injury; Adolescent; Adult; Biopsy; Eclampsia; Female; Fetal Viability; Fibrinogen; Fluorescent Antibody Technique; Glomerulonephritis; Humans; Hypertension; Immunoglobulin A; Kidney; Methyldopa; Nephrotic Syndrome; Pre-Eclampsia; Pregnancy; Pregnancy Complications; Pregnancy Complications, Cardiovascular | 1980 |